trending Market Intelligence /marketintelligence/en/news-insights/trending/RS--Aoe44W2bhnVeTpBzGA2 content esgSubNav
In This List

Celsion to raise $15M in common stock offering

Blog

Post-webinar Q&A: Global Credit Risk Trends 2021 and Beyond

Blog

University Essentials: From Crisis to Resilience – Navigating Sustainable Recovery

Blog

EV impact; vaccines to boost job market; coal supply constraints

Blog

Shore Capital is Now Available in S&P Global’s Aftermarket Research Collection


Celsion to raise $15M in common stock offering

Celsion Corp. is looking to raise up to $15 million in a common stock offering with Aspire Capital Fund LLC, a Chicago-based investment fund specializing in open market and direct equity investments in public companies.

Under the agreement, Aspire will buy up to 100,000 Celsion common shares per business day within a 24-month period.

In addition, Aspire may increase the number of common shares it will purchase for up to 2 million per business day.

Lawrenceville, N.J.-based Celsion develops and commercializes directed chemotherapy, DNA-mediated immunotherapy and RNA-based therapy products to treat cancer.